(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
JOUNCE THERAPEUTICS, INC. | ||||||||
Date: March 30, 2023 | By: | /s/ Kim C. Drapkin | ||||||
Kim C. Drapkin | ||||||||
Treasurer and Chief Financial Officer |
Cover Page |
Mar. 26, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Mar. 26, 2023 |
Entity Registrant Name | JOUNCE THERAPEUTICS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-37998 |
Entity Tax Identification Number | 45-4870634 |
Entity Address, Address Line One | 780 Memorial Drive |
Entity Address, City or Town | Cambridge, |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02139 |
City Area Code | (857) |
Local Phone Number | 259-3840 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | JNCE |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001640455 |
Amendment Flag | false |
[AICV!^AOD
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end